OXFBD02（Cat No.:R064172）is a selective small molecule inhibitor that targets specific enzymes or signaling pathways involved in cellular processes such as proliferation, migration, and survival. It has shown potential in modulating pathways related to cancer, neurodegeneration, and inflammation. By blocking its target, OXFBD02 can interfere with abnormal cellular activities, offering a promising tool for research into therapeutic interventions for various diseases. It is primarily used in preclinical studies to better understand disease mechanisms and assess the efficacy of new treatment strategies that could lead to novel therapeutic approaches.